MPX International (FRA:2J6) Debt-to-EBITDA : -2.03 (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is MPX International Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MPX International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €5.95 Mil. MPX International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €12.18 Mil. MPX International's annualized EBITDA for the quarter that ended in Mar. 2022 was €-8.91 Mil. MPX International's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2022 was -2.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MPX International's Debt-to-EBITDA or its related term are showing as below:

FRA:2J6's Debt-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

MPX International Debt-to-EBITDA Historical Data

The historical data trend for MPX International's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Debt-to-EBITDA Chart

MPX International Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Debt-to-EBITDA

-0.63

-0.32

-0.30

-1.17

MPX International Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Debt-to-EBITDA	Get a 7-Day Free Trial												-0.54	29.27	-0.52	-4.13	-2.03

Competitive Comparison of MPX International's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MPX International's Debt-to-EBITDA falls into.

MPX International Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MPX International's Debt-to-EBITDA for the fiscal year that ended in Sep. 2021 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.837	+	7.738)	/	-10.739
	=	-1.17

MPX International's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(5.949	+	12.176)	/	-8.912
	=	-2.03

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2022) EBITDA data.

MPX International (FRA:2J6) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

MPX International Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MPX International's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

MPX International (FRA:2J6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (FRA:2J6) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4

Website

https://www.mpxinternationalcorp.com

MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (FRA:2J6) Headlines

No Headlines